Baseline characteristics of participants in the LANDMARC trial: A 3‐year, pan ‐india, prospective, longitudinal study to assess management and real‐world outcomes of diabetes mellitus-Reference-Cited by-同舟云学术

Baseline characteristics of participants in the LANDMARC trial: A 3‐year, pan ‐india, prospective, longitudinal study to assess management and real‐world outcomes of diabetes mellitus

Published:2021-02-08 Issue:3 Volume:4 Page:
ISSN:2398-9238
Container-title:Endocrinology, Diabetes & Metabolism
language:en
Short-container-title:Endocrinol Diab Metab

Author:

Das Ashok K.¹^ORCID,Mithal Ambrish²,Joshi Shashank³,Kumar K. M. Prasanna⁴,Kalra Sanjay⁵^ORCID,Unnikrishnan A. G.⁶,Thacker Hemant⁷,Sethi Bipin⁸,Ghosh Romik⁹^ORCID,Kanade Vaishali¹⁰,Nair Arjun⁹,Mohanasundaram Senthilnathan⁹,Menon Shalini K.⁹,Chodankar Deepa¹⁰,Salvi Vaibhav¹⁰,Trivedi Chirag¹⁰,Chatterjee Godhuli¹⁰,Chowdhury Subhankar¹¹,Rais Nadeem¹²,Wangnoo Subhash K.¹³,Zargar Abdul H.¹⁴

Affiliation:

1. Pondicherry Institute of Medical Sciences (PIMS Puducherry India

2. Medanta ‐ The Medicity Gurgaon India

3. Lilavati Hospital Mumbai India

4. Centre for Diabetes and Endocrine Care Bengaluru India

5. Bharti Hospital Karnal India

6. Chellaram Diabetes Institute Pune India

7. Bhatia Hospital Mumbai India

8. Care Hospitals Hyderabad India

9. Sanofi India Ltd Mumbai India

10. Sanofi‐Synthelabo India Ltd Mumbai India

11. IPGME & R and SSKM Hospital Kolkata India

12. Chowpatti Medical Centre Mumbai India

13. Apollo Hospital Education and Research Foundation New Delhi India

14. Center for Diabetes & Endocrine Care Srinagar India

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/edm2.231

Reference24 articles.

1. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

2. International Diabetes Federation.Diabetes Atlas 9th edition. (2020a). Retrieved fromhttps://www.idf.org/our‐network/regions‐members/south‐east‐asia/welcome.html

3. International Diabetes Federation.Diabetes Atlas 9th edition. (2020b). Retrieved fromhttps://www.idf.org/our‐network/regions‐members/south‐east‐asia/diabetes‐in‐sea.html

4. International Diabetes Federation.Diabetes Atlas 9th edition. (2020c). Retrieved fromhttps://diabetesatlas.org/en/sections/demographic‐and‐geographic‐outline.html

5. Standards of Medical Care for Patients With Diabetes Mellitus

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Evidence and Practice-Based Guidelines on the Utility of Basal Insulin Combined Oral Therapy (Metformin and Glimepiride) in the Current Era;Current Diabetes Reviews;2023-10

2. The LongitudinAl Nationwide stuDy on Management And Real‐world outComes of diabetes in India over 3 years (LANDMARC trial);Endocrinology, Diabetes & Metabolism;2023-07

3. Two‐year trends from the LANDMARC study: A 3‐year, pan‐India, prospective, longitudinal study on the management and real‐world outcome in patients with type 2 diabetes mellitus;Endocrinology, Diabetes & Metabolism;2023-02

4. Pharmacokinetic Similarity between Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 and Originator Insulin Aspart Mix 70/30 (NovoMix 30) in Indian Adults with Type 2 Diabetes;Indian Journal of Endocrinology and Metabolism;2022-07

5. One‐year trends from the LANDMARC trial: A 3‐year, pan‐India, prospective, longitudinal study on the management and real‐world outcomes of type 2 diabetes mellitus;Endocrinology, Diabetes & Metabolism;2021-12